Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Update: Only 5% of US children ages 8–11 follow guidelines recommended for brain development

___

Dear read­er,

Time for Sharp­Brains month­ly e-newslet­ter, dis­cussing the lat­est inno­va­tions for brain health and men­tal health, and open­ing in this occa­sion with an impor­tant wake-up call.

New research:

New tools:

 

Hap­py Hal­loween and have a great month of Novem­ber,

 

The Sharp­Brains Team

Anticipating ethical implications of DARPA’s neurotechnology push

___

The Pentagon’s Push to Pro­gram Sol­diers’ Brains (The Atlantic):

…darpa offi­cials refer to the poten­tial con­se­quences of neu­rotech­nol­o­gy by invok­ing the acronym elsi, a term of art devised for the Human Genome Project. It stands for “eth­i­cal, legal, social impli­ca­tions.” The man who led the dis­cus­sion on ethics among the research teams Read the rest of this entry »

Helius Medical and HealthTech Connex partner to develop neuroplasticity clinics in Canada

___

Helius Med­ical Tech­nolo­gies and HealthTech Con­nex Announce Alliance to Build Cana­di­an Com­mer­cial Infra­struc­ture (press release):

Helius Med­ical Tech­nolo­gies, Inc. (NASDAQ:HSDT) (TSX:HSM), a neu­rotech com­pa­ny focused on neu­ro­log­i­cal well­ness, today announced that the Com­pa­ny has entered into an agree­ment with HealthTech Con­nex, Inc. (“HTC”) to devel­op and man­age neu­ro­plas­tic­i­ty clin­ics in Cana­da. Read the rest of this entry »

On neuroplasticity, psychedelics, forest bathing, drinking, sleep and more: The Month in Review

___

Dear read­er,

It’s time for Sharp­Brains month­ly e-newslet­ter explor­ing the lat­est think­ing, sci­ence and tools for life­long brain health and men­tal well-being.

Enjoy!

New research:

New thinking:

New tools:

 

Have a great month of Sep­tem­ber, and please take a moment to share this e-newslet­ter with some­one who may enjoy it 🙂

 

The Sharp­Brains Team

Study: Psychedelics can promote neural plasticity in the prefrontal cortex and expand pathways for mental health

– Cred­it: Cell Reports 2018 23, 3170–3182DOI: (10.1016/j.celrep.2018.05.022). Copy­right © 2018 The Authors

___

Psy­che­delics in Neu­rol­o­gy: Poten­tial for Improv­ing Neu­ro­plas­tic­i­ty (Neu­rol­o­gy­Times):

Back in the 1950s, research was prov­ing that psy­che­del­ic agents could be effec­tive in the treat­ment of var­i­ous neu­ropsy­chi­atric dis­or­ders. Unfor­tu­nate­ly, just as sci­ence was explor­ing their ben­e­fi­cial effects, the coun­ter­cul­ture was explor­ing and embrac­ing their effects. Slow­ly but sure­ly, psy­che­delics were asso­ci­at­ed with rebel­lious youth and the tumul­tuous anti-war move­ment. As a result, the gov­ern­ment shut down most of the research.

The 1990s saw renewed inter­est in psy­che­del­ic com­pounds as a means to address neu­ropsy­chi­atric dis­or­ders. Research explored the ben­e­fits of MDMA and ket­a­mine to treat mood dis­or­ders and post­trau­mat­ic stress dis­or­der. Now, a new study sheds even more light on the promise these agents might pro­vide. Read the rest of this entry »

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives

Enter Your Email to receive Sharp­Brains free, monthly eNewslet­ter:

Join more than 50,000 Sub­scribers and stay informed and engaged.